Insulin Pump Therapy is Equally Effective and Safe in Elderly and Young Type 1 Diabetes Patients
- 1 January 2011
- journal article
- research article
- Published by Raiya Academic International LLC in The Review of Diabetic Studies
- Vol. 8 (2) , 254-258
Abstract
It is generally accepted that in adult type 1 diabetes patients (T1D) continuous subcutaneous insulin infusion (CSII) via a personal pump is more effective than the multiple daily injections (MDI) model. However, it is not clear whether all age groups of adult T1D patients may equally benefit from CSII therapy. We aimed to compare the glycemic control and use of selected pump tools in T1D subjects using CSII over the age of 50 (50+ T1D) with patients younger than 50 years of age. The last available insulin pump/blood glucose meter downloads and last available HbA1c levels of 124 adult T1D subjects using CSII were reviewed. We divided our cohort into two subgroups: 50+ T1D patients (n = 13) and younger patients (n = 111). There were no differences in glycemic control achieved with CSII treatment in 50+ T1D patients vs. younger subjects. HbA1c levels were 7.01 ± 0.67% and 7.34 ± 1.24% (p = 0.46), and the mean glycemia based on glucometer downloads was 141.8 ± 17.7 mg/dl and 150.8 ± 35.7 mg/dl (p = 0.69), respectively. Also, there were no differences with respect to the use of important personal pump options and tools. In conclusion, insulin pump therapy appears to be effective and safe in T1D patients regardless of age.Keywords
This publication has 19 references indexed in Scilit:
- Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 DiabetesNew England Journal of Medicine, 2011
- Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adultsPediatric Diabetes, 2011
- Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetesDiabetes Research and Clinical Practice, 2011
- Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitusCochrane Database of Systematic Reviews, 2010
- Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapyDiabetes/Metabolism Research and Reviews, 2009
- Clinical Usefulness of a Bolus Calculator in Maintaining Normoglycaemia in Active Professional Patients with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin InfusionJournal of International Medical Research, 2008
- Treatment of diabetes mellitus using an external insulin pump: the state of the artDiabetes & Metabolism, 2008
- Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trialDiabetic Medicine, 2005
- Continuous Subcutaneous Insulin Infusion at 25 YearsDiabetes Care, 2002
- Beneficial Effects of Continuous Subcutaneous Insulin Infusion in Older Patients with Long-Standing Type 1 DiabetesEndocrine Practice, 2001